ANGIOGENEX, INC. Forms 3, 4 and 5: Corporate Securities (Bonds and Notes)
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 3 rows, 3 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2021-11-02: Reporting owner ARONSTEIN MICHAEL; Form 5; Security Convertible Note; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2008-02-14: Reporting owner Strage Michael M; Form 3/A; Security Convertible Promissory Note; Transaction Holding.
- 2008-02-14: Reporting owner Salvador Richard; Form 3/A; Security Convertible Promissory Note; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2021-11-02 | ARONSTEIN MICHAEL Director | 5 | Convertible Note Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +240,000 5,240,000 owned after | $0.25 | 2022-02-15 | |
| 2008-02-14 holding as of filing | Strage Michael M Director, Officer (VP), 10% Owner | 3/A | Convertible Promissory Note Derivative · Direct | Holding | $0.14 exercise price | 2008-02-14 | ||
| 2008-02-14 holding as of filing | Salvador Richard Director, Officer (President, CEO), 10% Owner | 3/A | Convertible Promissory Note Derivative · Direct · (m) | Holding | $0.14 exercise price | 2008-02-14 |